Determining Benefit of Ovarian Function Suppression: SOFT Trial

Ovarian function suppression in premenopausal women with breast cancerПодробнее

Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Br...Подробнее

Ovarian Suppression in Metastatic HR+ Breast CancerПодробнее

The Ovaries…To Suppress or Not? That is the Question! presented by Jay Andersen, MDПодробнее

Dr. Rao on the SOFT Trial in Patients With Premenopausal Breast CancerПодробнее

Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast ...Подробнее

Dr. Francis on the Benefits of Ovarian Suppression for Younger WomenПодробнее

Breast Cancer | Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Manag...Подробнее

Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & durationПодробнее

Two trials, SOFT and TEXT, investigating combination treatments for patients with breast cancerПодробнее

Beth Overmoyer Discusses Role of Ovarian Suppression in Young, High-Risk WomenПодробнее

Comparing adjuvant tamoxifen with ovarian function suppression via exomestane to tamoxifen aloneПодробнее

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer casesПодробнее

Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Br...Подробнее

Breast cancer: Adjuvant exemestane combined with ovarian function suppression better than tamoxifenПодробнее

Determining Endocrine Therapy for Premenopausal Breast Cancer Patients: Practical ConsiderationsПодробнее

Ovarian suppression with tamoxifen reduced recurrence for some women with PBCПодробнее

Partridge: Ovarian Function Suppression in Young Breast Cancer PatientsПодробнее

Ovarian Function Suppression for Breast Cancer: Lupron or Zoladex- Monthly or Every 3 Months?Подробнее